Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignace Vergote

Showing results (511-520 of 578) with videos related to

Pageof 58
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Incorporation of pazopanib in maintenance therapy of ovarian cancerAndreas du Bois, Anne Floquet, Jae-Weon Kim, et al.
The New England Journal of Medicine|February 9, 2022
Survival with Cemiplimab in Recurrent Cervical CancerKrishnansu S Tewari, Bradley J Monk, Ignace Vergote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2011
Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patientsR Stephanie Huang, Sharon E Johnatty, Eric R Gamazon, et al.
Gynecologic Oncology|July 1, 2026
Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancerMark S Shahin, Domenica Lorusso, Floor J Backes, et al.
Gynecologic Oncology|January 22, 2022
Clear cell carcinoma of the endometriumGiorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 31, 2025
Uterine leiomyosarcomaGiorgio Bogani, Giuseppe Caruso, Isabelle Ray-Coquard, et al.
Cancer Research Communications|October 30, 2025
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid TumorsKristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 30, 2022
Endometrial carcinosarcomaGiorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
Cancers|May 6, 2020
Central Pathology Review in SENTIX, A Prospective Observational International Study on Sentinel Lymph Node Biopsy in Patients with Early-Stage Cervical Cancer (ENGOT-CX2)Kristyna Nemejcova, Roman Kocian, Christhardt Kohler, et al.
Lancet (London, England)|June 5, 2025
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trialAlexander B Olawaiye, Laurence Gladieff, David M O'Malley, et al.
Pageof 58

Showing results (511-520 of 578) with videos related to

Sort By:
Pageof 58
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Incorporation of pazopanib in maintenance therapy of ovarian cancerAndreas du Bois, Anne Floquet, Jae-Weon Kim, et al.
The New England Journal of Medicine|February 9, 2022
Survival with Cemiplimab in Recurrent Cervical CancerKrishnansu S Tewari, Bradley J Monk, Ignace Vergote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2011
Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patientsR Stephanie Huang, Sharon E Johnatty, Eric R Gamazon, et al.
Gynecologic Oncology|July 1, 2026
Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancerMark S Shahin, Domenica Lorusso, Floor J Backes, et al.
Gynecologic Oncology|January 22, 2022
Clear cell carcinoma of the endometriumGiorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 31, 2025
Uterine leiomyosarcomaGiorgio Bogani, Giuseppe Caruso, Isabelle Ray-Coquard, et al.
Cancer Research Communications|October 30, 2025
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid TumorsKristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 30, 2022
Endometrial carcinosarcomaGiorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, et al.
Cancers|May 6, 2020
Central Pathology Review in SENTIX, A Prospective Observational International Study on Sentinel Lymph Node Biopsy in Patients with Early-Stage Cervical Cancer (ENGOT-CX2)Kristyna Nemejcova, Roman Kocian, Christhardt Kohler, et al.
Lancet (London, England)|June 5, 2025
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trialAlexander B Olawaiye, Laurence Gladieff, David M O'Malley, et al.
Pageof 58